NASDAQ:AGTC - Applied Genetic Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.04 -0.10 (-3.18 %)
(As of 01/17/2019 08:30 AM ET)
Previous Close$3.14
Today's Range$3.02 - $3.20
52-Week Range$2.26 - $7.50
Volume131,272 shs
Average Volume155,411 shs
Market Capitalization$56.93 million
P/E Ratio-2.58
Dividend YieldN/A
Beta2.77
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which is a disease of the central nervous system and otology. It has collaboration agreements with Biogen MA, Inc., Synpromics Limited, and Bionic Sight, LLC, as well as the University of Florida Research Foundation. The company was founded in 1999 and is headquartered in Alachua, Florida.

Receive AGTC News and Ratings via Email

Sign-up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AGTC
CUSIPN/A
Phone386-462-2204

Debt

Current Ratio4.32
Quick Ratio4.32

Price-To-Earnings

Sales & Book Value

Annual Sales$24.19 million
Price / Sales2.28
Price / Cash FlowN/A
Book Value$5.48 per share
Price / Book0.55

Profitability

Net Income$-21,300,000.00
Net Margins-67.02%
Return on Assets-15.19%

Miscellaneous

Employees78
Market Cap$56.93 million
OptionableOptionable

Applied Genetic Technologies (NASDAQ:AGTC) Frequently Asked Questions

What is Applied Genetic Technologies' stock symbol?

Applied Genetic Technologies trades on the NASDAQ under the ticker symbol "AGTC."

How were Applied Genetic Technologies' earnings last quarter?

Applied Genetic Technologies Corp (NASDAQ:AGTC) announced its quarterly earnings results on Thursday, November, 8th. The biotechnology company reported $0.07 EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.50) by $0.57. The biotechnology company earned $14.03 million during the quarter, compared to analyst estimates of $2.90 million. Applied Genetic Technologies had a negative return on equity of 18.97% and a negative net margin of 67.02%. View Applied Genetic Technologies' Earnings History.

When is Applied Genetic Technologies' next earnings date?

Applied Genetic Technologies is scheduled to release their next quarterly earnings announcement on Friday, February 8th 2019. View Earnings Estimates for Applied Genetic Technologies.

What price target have analysts set for AGTC?

6 Wall Street analysts have issued twelve-month target prices for Applied Genetic Technologies' stock. Their predictions range from $5.00 to $15.00. On average, they anticipate Applied Genetic Technologies' stock price to reach $8.00 in the next year. This suggests a possible upside of 163.2% from the stock's current price. View Analyst Price Targets for Applied Genetic Technologies.

What is the consensus analysts' recommendation for Applied Genetic Technologies?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied Genetic Technologies in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Applied Genetic Technologies.

Has Applied Genetic Technologies been receiving favorable news coverage?

Media stories about AGTC stock have been trending somewhat negative this week, according to InfoTrie. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Applied Genetic Technologies earned a news impact score of -1.6 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future.

Who are some of Applied Genetic Technologies' key competitors?

Who are Applied Genetic Technologies' key executives?

Applied Genetic Technologies' management team includes the folowing people:
  • Ms. Susan B. Washer, Pres, CEO & Director (Age 57)
  • Mr. William A. Sullivan, Chief Financial Officer (Age 47)
  • Dr. Matthew Feinsod, Interim Chief Medical Officer (Age 47)
  • Dr. Nicholas Muzyczka, Co-Founder
  • Dr. Barry J. Byrne, Co-Founder

How do I buy shares of Applied Genetic Technologies?

Shares of AGTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Applied Genetic Technologies' stock price today?

One share of AGTC stock can currently be purchased for approximately $3.04.

How big of a company is Applied Genetic Technologies?

Applied Genetic Technologies has a market capitalization of $56.93 million and generates $24.19 million in revenue each year. The biotechnology company earns $-21,300,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis. Applied Genetic Technologies employs 78 workers across the globe.

What is Applied Genetic Technologies' official website?

The official website for Applied Genetic Technologies is http://www.agtc.com.

How can I contact Applied Genetic Technologies?

Applied Genetic Technologies' mailing address is 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615. The biotechnology company can be reached via phone at 386-462-2204.


MarketBeat Community Rating for Applied Genetic Technologies (NASDAQ AGTC)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  324 (Vote Outperform)
Underperform Votes:  201 (Vote Underperform)
Total Votes:  525
MarketBeat's community ratings are surveys of what our community members think about Applied Genetic Technologies and other stocks. Vote "Outperform" if you believe AGTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel